These findings suggest that the increased ATP5b plays an important adaptive or protective role in decreasing the rate of AGEs-induced renal fibrosis during diabetic condition, which may give evidence for developing new therapeutic approaches against the progression of renal fibrosis in early stage of diabetes. Here, ATP5F1B is linked to renal fibrosis.